Procaps Group Sa logo

Procaps Group Sa Share Price (NASDAQ: PROC)

▲

-1.59

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 3 Feb 2025

Check the interactive Procaps Group Sa Stock chart to analyse performance

Procaps Group Sa Key Stats

Check Procaps Group Sa key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.5907
Open
$0.95
Market Capitalization
$179.5M
Today's Volume
$659.0K
Revenue TTM
$414.1M
EBITDA
$57.1M
Earnings Per Share (EPS)
$0.51
PE Ratio
3.12
Profit Margin
12.61%
Quarterly Earnings Growth YOY
-0.64%
Return On Equity TTM
37.37%

Global Institutional Holdings in Procaps Group Sa

  • Name

    Holdings %

  • Exome Asset Management LLC

    0.11%

  • Geode Capital Management, LLC

    0.03%

  • Activest Wealth Management

    0.01%

Analyst Recommendation on Procaps Group Sa Stock

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Procaps Group Sa(by analysts ranked 0 to 5 stars)

Procaps Group Sa Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY23Y/Y Change
Revenue
$414.1M
↑ 1.02%
Net Income
$52.2M
↑ 22.72%
Net Profit Margin
12.61%
↑ 2.23%

About Procaps Group Sa

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.
Organization
Procaps Group Sa
Employees
5500
CEO
Mr. Jose Antonio Toledo Vieira
Industry
Miscellaneous

Key Management of Procaps Group Sa

NameTitle
Mr. Jose Antonio Toledo Vieira
Chief Executive Officer
Mr. Daniel Bernal
Interim Chief Financial Officer
Dr. Camilo Camacho
Chief Operations Officer
Ms. Melissa Angelini
Interim VP of Finance & Investor Relations Director
Ms. Marcela Carvajalino Pagano
Vice-President of Corporate & Legal Affairs
Mr. Luis Alberto Palacios Aragon
Vice-President of International Marketing and R&D
Mr. Mauricio Castaneda Caballero
Vice-President of Human Resources
Mr. Patricio Vargas Munoz
Chief Optimization and Rationalization Officer

Important FAQs about investing in PROC Stock from India :

What is Procaps Group Sa share price today?

Procaps Group Sa share price today is as on at the close of the market. Procaps Group Sa share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Procaps Group Sa share?

Procaps Group Sa share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Procaps Group Sa stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Procaps Group Sa Stock (PROC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Procaps Group Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Procaps Group Sa Shares .

What is the minimum amount required to buy Procaps Group Sa Stock (PROC) from India?

Indian investors can start investing in Procaps Group Sa (PROC) shares with as little as ₹88.6975 or $1 (as of November 09, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹886.98 in Procaps Group Sa stock (as per the Rupee-Dollar exchange rate as on November 09, 2025). Learn more about fractional shares .

What are the returns that Procaps Group Sa has given to Indian investors in the last 5 years?

Procaps Group Sa stock has given 0.0% share price returns and 19.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?